pandemic
-
CSL welcomes pandemic agreement
CSL Biotherapies welcomes news of a decision by the World Health Assembly to adopt the Pandemic Influenza Preparedness Framework for the Sharing of Influenza Viruses and Access to Vaccines and Other Benefits. The Framework is the culmination of se…
pandemic | 20 May 2011
-
PPD and Southern Research Institute Sign Agreement for Clinical Research Services
PPD and Southern Research Institute have formed a collaborative agreement in pandemic and seasonal influenza vaccine research and development. This is to provide clients a full spectrum of influenza vaccine development services by collaborating on cl…
pandemic | 24 March 2010
-
GlaxoSmithKline: Government Orders for Pandemic (H1N1) 2009 Vaccine
GlaxoSmithKline (GSK) has confirmed that it has contracts in place to supply 195 million doses of its pandemic (H1N1) 2009 adjuvanted influenza vaccine. It has a variety of agreements in place with the US government to supply pandemic products worth …
pandemic | 10 August 2009
-
Australian Government Stockpiles 1.6 million Courses of Relenza
Biota Holdings has announced that the Australian government has purchased an additional 1.6 million courses of Relenza for the National Medical Stockpile to bolster supplies of antiviral drugs to treat pandemic influenza. The purchase cost is A$43 mi…
pandemic | 08 June 2009
-
Pandemic Flu: Gaps In Preparedness Remain
Responding to growing fear of a flu pandemic over recent years, many governments around the world, encouraged by the WHO, have developed pandemic preparedness plans. These strategies encompass a range of measures including the stockpiling of antivira…
pandemic | 22 May 2009
-
Scientists call for the diversification of antiviral stockpiles in preparation for an influenza pandemic
GlaxoSmithKline welcomes the publication today in Nature of the article 'The mechanism of H5N1 Influenza resistance to Tamiflu and implications for drug stockpiles' in which the authors state ''our results indicate that it would be prudent for pandem…
pandemic | 20 May 2008
-
New Study of Candidate Pre-pandemic Flu Vaccine Demonstrates Immunogenecity and Favorable Safety Profile for Asians
GlaxoSmithKline (GSK) announced that data from its Asian H5N1 vaccine clinical trial demonstrated for the first time that its candidate pre-pandemic H5N1 vaccine adjuvant with GSK's proprietary Adjuvant System (GSK's candidate pre-pandemic vaccine) e…
pandemic | 01 March 2008
-
PATH Study: $2-10B Needed For Vaccine Access For Influenza Pandemic Preparedness
If an influenza pandemic occurred in 2007, fewer than one-fifth of the approximately 13 billion vaccine doses needed to fully vaccinate the global population would be available within six months in a best-case scenario. A new study entitled Influ…
pandemic | 21 December 2007
-
Intergovernmental Meeting On Pandemic Influenza Preparedness
The Member States of the World Health Organization (WHO) has met in Geneva from 20-23 November to discuss the sharing of influenza viruses and the benefits of such cooperation, which include access to vaccines. This meeting follows an August 2007 …
pandemic | 30 November 2007
-
NIH Scientists Target Future Pandemic Strains of H5N1 Avian Influenza
Preparing vaccines and therapeutics that target a future mutant strain of H5N1 influenza virus sounds like science fiction, but it may be possible, according to a team of scientists at the National Institute of Allergy and Infectious Diseases (NIAID)…
pandemic | 13 August 2007
